.

Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
Merck
Argus Health
Fuji
Baxter
Mallinckrodt
Accenture
Federal Trade Commission
QuintilesIMS

Generated: February 25, 2018

DrugPatentWatch Database Preview

Patents Expiring in January 2028

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Mobius TherapMITOSOLmitomycinFOR SOLUTION;TOPICAL022572-001Feb 7, 2012RXYesYes➤ Sign Up➤ Sign UpYYMITOSOL IS AN ANTIMETABOLITE INDICATED AS AN ADJUNCT TO AB EXTERNO GLAUCOMA SURGERY. IT IS INTENDED FOR TOPICAL APPLICATION TO THE SITE OF GLAUCOMA FILTRATION SURGERY
Dow PharmJUBLIAefinaconazoleSOLUTION;TOPICAL203567-001Jun 6, 2014RXYesYes➤ Sign Up➤ Sign UpTOPICAL TREATMENT OF ONYCHOMYCOSIS OF THE TOENAIL(S) DUE TO TRICHOPHYTON RUBRUM AND TRICHOPHYTON MENTAGROPHYTES
Dow PharmJUBLIAefinaconazoleSOLUTION;TOPICAL203567-001Jun 6, 2014RXYesYes➤ Sign Up➤ Sign UpTOPICAL TREATMENT OF ONYCHOMYCOSIS OF THE TOENAIL(S) DUE TO TRICHOPHYTON RUBRUM AND TRICHOPHYTON MENTAGROPHYTES
Horizon PharmaRAYOSprednisoneTABLET, DELAYED RELEASE;ORAL202020-003Jul 26, 2012ABRXYesYes➤ Sign Up➤ Sign UpYTREATMENT OF RHEUMATOLOGIC, ALLERGIC, PULMONARY,GASTROINTESTINAL,DERMATOLOGIC DISEASES OR CONDITIONS BY THE USE OF A DELAYED RELEASE 5MG PREDNISONE TABLET
Janssen ProdsYONDELIStrabectedinPOWDER;IV (INFUSION)207953-001Oct 23, 2015RXYesYes➤ Sign Up➤ Sign UpY
ApilATELVIArisedronate sodiumTABLET, DELAYED RELEASE;ORAL022560-001Oct 8, 2010ABRXYesYes➤ Sign Up➤ Sign UpYTREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN
ApilATELVIArisedronate sodiumTABLET, DELAYED RELEASE;ORAL022560-001Oct 8, 2010ABRXYesYes➤ Sign Up➤ Sign UpYTREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN
Takeda Pharms UsaDEXILANTdexlansoprazoleCAPSULE, DELAYED RELEASE;ORAL022287-001Jan 30, 2009RXYesNo➤ Sign Up➤ Sign UpY
Shionogi IncSYMPROICnaldemedine tosylateTABLET;ORAL208854-001Mar 23, 2017RXYesYes➤ Sign Up➤ Sign UpYY
Takeda Pharms UsaDEXILANTdexlansoprazoleCAPSULE, DELAYED RELEASE;ORAL022287-002Jan 30, 2009ABRXYesYes➤ Sign Up➤ Sign UpY
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
US Department of Justice
Baxter
Covington
Daiichi Sankyo
Express Scripts
McKinsey
Fuji
Moodys
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot